alternatives to glp 1 agonists Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research alternative to glp 1 Possible
Description
Lilly is currently testing retatrutide in late-stage trials.
Additionally, innovations in drug delivery methods, such as weekly dosing formulations, further enhance patient compliance, solidifying the dominance of this segment
The anti-inflammatory properties significantly aid in the therapy of metabolic syndrome
Collaboration NCDRF
